All In Biotech

Drug Trial Radar · NCT05389696

Clinical Trial to Evaluate Pharmacokinetic Characteristics of MIT-001 After SC Administration in Healthy Subjects

Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetic Characteristics of MIT-001 After Subcutaneous and Intravenous Administration in Healthy Subjects

Last checked: Nov 19, 2026Latest source record: Aug 24, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

40

Actual

Start

May 13, 2022

Primary completion

Feb 13, 2023

Study completion Apr 28, 2023

Sponsor

Lead sponsor
MitoImmune TherapeuticsIndustry
Sponsor type
Industry
First posted
May 25, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Other
FDA-regulated drug
No
Who can join
All sexes, from 19 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

1. Part 1 Randimization, Double blinded, Placebo controlled, Dose escalation(10mg, 20mg, 40mg) of MIT-001 SC or IV single administration to evaluate safety, tolerability and PK in healthy adult. 2. Part2 Randimization, Double blinded, Placebo controlled, MIT-001 SC multiple administration for 7days (20mg \& 40mg) to evaluate safety, tolerability and PK in healthy adult.

Conditions

  • Heathly Subjects

Interventions

  • Single subcutaneous administration and Blood collectionDrug

    Single subcutaneous administration and Blood collection

  • Single subcutaneous administration and then IV injection.Drug

    Single subcutaneous administration and then single intravenous administration after 2 weeks. In addition Blood collection is conducted as scheduled.

  • MIT-001 20mg and 40mg_Multiple administrationDrug

    Multiple subcutaneous administration for 7 days and then blood collection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. PK_Cmax_Part1 Group 1&2Time frame: Part1. Group 1&2: Before SC administration(Day0, 0hour) to 144hour after administration 16 points.
  2. PK_Cmax_Part1 Group 3Time frame: Part1. Group 3_Before SC administration(Day0, 0hour) to 144hour 16 points and then Before IV administration on 15th day(0hour) to 144hour after IV administration 17points.
  3. PK_AUClast_Part1 Group 1&2Time frame: Part1. Group 1&2_Before SC administration(Day0, 0hour) to 144hour after administration 16 points.
  4. PK_AUClast_Part1 Group 3Time frame: Part1. Group 3_Before SC administration(Day0, 0hour) to 144hour 16 points and then Before IV administration on 15th day(0hour) to 144hour after IV administration 17points.
  5. PK_AUCinf_Part 1, Group 1&2Time frame: Part1. Group 1&2_Before SC administration(Day0, 0hour) to 144hour after administration 16 points.
  6. PK_AUCinf_Part 1, Group 3Time frame: Part1. Group 3_Before SC administration(Day0, 0hour) to 144hour 16 points and then Before IV administration on 15th day(0hour) to 144hour after IV administration 17points.
  7. PK_Tmax_Part 1, Group 1&2Time frame: Part1. Group 1&2_Before SC administration(Day0, 0hour) to 144hour after administration 16 points.
  8. PK_Tmax_Part 1, Group 3Time frame: Part1. Group 3_Before SC administration(Day0, 0hour) to 144hour 16 points and then Before IV administration on 15th day(0hour) to 144hour after IV administration 17points.
  9. PK_t1/2_Part 1, Group 1&2Time frame: Part1. Group 1&2_Before SC administration(Day0, 0hour) to 144hour after administration 16 points.
  10. PK_t1/2_Part 1, Group 3Time frame: Part1. Group 3_Before SC administration(Day0, 0hour) to 144hour 16 points and then Before IV administration on 15th day(0hour) to 144hour after IV administration 17points.
  11. PK_Vd/F_Part 1, Group 1&2Time frame: Part1. Group 1&2_Before SC administration(Day0, 0hour) to 144hour after administration 16 points.
  12. PK_Vd/F_Part 1, Group 3Time frame: Part1. Group 3_Before SC administration(Day0, 0hour) to 144hour 16 points and then Before IV administration on 15th day(0hour) to 144hour after IV administration 17points.
  13. PK_CL/F_Part 1, Group 1,2Time frame: Part1. Group 1&2_Before SC administration(Day0, 0hour) to 144hour after administration 16 points.
  14. PK_CL/F_Part 1, Group 3Time frame: Part1. Group 3_Before SC administration(Day0, 0hour) to 144hour 16 points and then Before IV administration on 15th day(0hour) to 144hour after IV administration 17points.
  15. PK_MRT_Part 1, Group 1&2Time frame: Part1. Group 1&2_Before SC administration(Day0, 0hour) to 144hour after administration 16 points.
  16. PK_MRT_Part 1, Group 3Time frame: Part1. Group 3_Before SC administration(Day0, 0hour) to 144hour 16 points and then Before IV administration on 15th day(0hour) to 144hour after IV administration 17points.
  17. PK_F_Part1, Group1,2Time frame: Part1. Group 1&2_Before SC administration(Day0, 0hour) to 144hour after administration 16 points.
  18. PK_F_Part1, Group3Time frame: Part1. Group 3_Before SC administration(Day0, 0hour) to 144hour 16 points and then Before IV administration on 15th day(0hour) to 144hour after IV administration 17points.
  19. PK_Part2_CmaxTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
  20. PK_Part2_CminTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
  21. PK_Part2_CavgTime frame: Par2_Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
  22. PK_Part2_AUCtauTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
  23. PK_Part2_TmaxTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
  24. PK_Part2_t1/2Time frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
  25. PK_Part2_Vd/FTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
  26. PK_Part2_CL/FTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
  27. PK_Part2_Cmax,ssTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
  28. PK_Part2_Cmin,ssTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
  29. PK_Part2_Cavg,ssTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
  30. PK_Part2_AUCtau,ssTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
  31. PK_Part2_Tmax,ssTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
  32. PK_Part2_t1/2,ssTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
  33. PK_Part2_Vdss/FTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
  34. PK_Part2_CLss/FTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
  35. PK_Part2_PTFTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points
  36. PK_Part2_RacTime frame: Part2: Before SC administration(Day0, 0hour) to 24hour 13points, Day5 0hour, Day6 0hour and then Day7 0hour to 216hour after SC administration 17points

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Seoul National University

    Seoul, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.